S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SWTX SpringWorks Therapeutics Inc

59.30

-0.63 (-1.05%)

Feb 21 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more SpringWorks Therapeutics Charts.

SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more SpringWorks Therapeutics Charts.

SpringWorks Therapeutics Inc News

Form 144 - Report of proposed sale of securities
Thursday 20 February 2025 (2 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 20 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 20 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 20 February 2025 (2 days ago) • Edgar (US Regulatory)

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Thursday 20 February 2025 (2 days ago) • GlobeNewswire Inc.

SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action Before Their Tumor Takes Over
Wednesday 19 February 2025 (3 days ago) • PR Newswire (US)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 February 2025 (1 week ago) • Edgar (US Regulatory)

UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Tuesday 11 February 2025 (1 week ago) • GlobeNewswire Inc.

SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Tuesday 11 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Monday 10 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 10 February 2025 (2 weeks ago) • Edgar (US Regulatory)

More SpringWorks Therapeutics Inc News Articles

Bell Buckle (PK)

Intergrated Cannabis Sol... (PK)

North Bay Resources (PK)

Mullen Automotive

Greater Cannabis (PK)

Super Micro Computer

Anavex Life Sciences

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions